abstract |
The present invention relates to a pharmaceutical combination comprising a 2-carboxamide cycloaminourea derivative compound of formula (I) and an inhibitor of heat shock protein 90, as well as a proliferative disease, more specifically a PI3K-dependent disease, more specifically Relates to the use of such combinations in the treatment of PI3K-α dependent diseases. |